Arcus Biosciences, Inc. (RCUS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -138M | -120M | -97M | -133M | -132M | -100M | 26M | -94M | -2M | -88M | -63M | -57M |
| Operating CF Margin % | -811.76% | -363.64% | -373.08% | -83.13% | -471.43% | -384.62% | 54.17% | -241.03% | -1.38% | -283.87% | -196.88% | -196.55% |
| Operating CF Growth % | -4.55% | -20% | -473.08% | -41.49% | -6500% | -13.64% | 141.27% | -64.91% | 97.96% | -26.18% | 22.18% | 12.31% |
| Net Income | -128M | -106M | -135M | 0 | -112M | -94M | -92M | -93M | -4M | -81M | -71M | -75M |
| Depreciation & Amortization | 2M | 3M | 2M | 2M | 3M | 3M | 2M | 2M | 3M | 5M | 1M | 2M |
| Stock-Based Compensation | 19M | 15M | 14M | 15M | 16M | 17M | 19M | 20M | 20M | 0 | 18M | 18M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -29M | 0 |
| Other Non-Cash Items | -31M | -2M | 1M | -2M | -2M | -3M | -4M | -4M | 16M | 12M | 27M | -2M |
| Working Capital Changes | 0 | -30M | 21M | -148M | -37M | -23M | 101M | -19M | -37M | -24M | -9M | 0 |
| Change in Receivables | 0 | 0 | 4M | 0 | 5M | -4M | 12M | 7M | 13M | 0 | 11M | -2M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6M | 0 |
| Change in Payables | -3M | 0 | 13M | 8M | 3M | 5M | -1M | 0 | -1M | 2M | 6M | -19M |
| Cash from Investing | 114M | -182M | 79M | 137M | 32M | 51M | -29M | 63M | -169M | 28M | 11M | 26M |
| Capital Expenditures | 0 | -1M | 0 | 0 | -1M | -1M | -1M | 0 | -4M | -6M | -10M | -5M |
| CapEx % of Revenue | - | 3.03% | - | - | 3.57% | 3.85% | 2.08% | - | 2.76% | 19.35% | 31.25% | 17.24% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -21M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21M | 0 |
| Cash from Financing | 3M | 286M | 8M | 52M | 142M | -2M | 48M | 2M | 229M | 3M | 6M | 23M |
| Debt Issued (Net) | 0 | 0 | 0 | 49M | 0 | 0 | 47M | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 286M | 8M | 3M | 142M | 0 | 0 | 3M | 228M | 3M | 5M | 20M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 3M | 0 | 0 | 0 | 0 | -2M | 1M | -1M | 1M | 0 | 1M | 3M |
| Net Change in Cash | -21M | -16M | -10M | 56M | 42M | -51M | 45M | -29M | 58M | -57M | -46M | -8M |
| Free Cash Flow | -138M | -121M | -97M | -133M | -133M | -101M | 25M | -94M | -6M | -94M | -73M | -62M |
| FCF Margin % | -811.76% | -366.67% | -373.08% | -83.13% | -475% | -388.46% | 52.08% | -241.03% | -4.14% | -303.23% | -228.13% | -213.79% |
| FCF Growth % | -3.76% | -19.8% | -488% | -41.49% | -2116.67% | -7.45% | 134.25% | -51.61% | 94.06% | -34.06% | 11.28% | 13.89% |
| FCF per Share | -1.10 | -1.13 | -0.91 | -1.25 | -1.35 | -1.10 | 0.27 | -1.03 | -0.07 | -1.25 | -0.98 | -0.85 |
| FCF Conversion (FCF/Net Income) | 1.08x | 1.22x | 0.72x | 16.63x | 1.18x | 1.06x | -0.28x | 1.01x | 0.50x | 1.09x | 0.89x | 0.76x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |